Gastroenterology Journal Articles

• I.V. Lidocaine and Propofol Use in Elderly Colonoscopy Patients Might intravenous lidocaine reduce propofol consumption in elderly patients undergoing colonoscopy? How might it impact the risk of adverse events?
  BMC Anesthesiology, April 25, 2022
• Ustekinumab Levels in Pregnant Women With IBD This study details the pharmacokinetics of ustekinumab in women with IBD who received the drug during pregnancy as well as in infants exposed in utero.
  Alimentary Pharmacology & Therapeutics, April 20, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022
• Integrating HCV Screening of Baby Boomers at a Hospital ED This paper details the implementation of an opt-in HCV screening program for baby boomers presenting to a community hospital emergency department.
  Journal of Viral Hepatitis, April 18, 2022
• Distant Metastatic Patterns and Prognosis in Thyroid Cancer Gain a better understanding of the relationship between clinicopathologic factors and metastatic patterns and the prognostic impacts in differentiated thyroid cancer.
  Clinical Endocrinology, April 14, 2022
• Progression in IBD With Indefinite and Low-grade Dysplasia What is the incidence of and risk factors for advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia?
  Alimentary Pharmacology & Therapeutics, April 13, 2022
• Immunosuppressive Drugs and COVID-19 Severity in AIH This study found that patients with autoimmune hepatitis who were taking certain immunosuppressants prior to the onset of COVID-19 had more severe courses of COVID-19.
  Liver International, April 11, 2022
• Tenofovir vs. Entecavir Therapy in HBV: Long-term Renal Safety Do tenofovir and entecavir differ in their long-term impact on renal function in patients with hepatitis B?
  Journal of Viral Hepatitis, April 11, 2022
• FODMAP-induced Symptom Generation in IBS This study aimed to elucidate the mechanisms underlying FODMAP-induced symptoms in patients with irritable bowel syndrome and healthy controls.
  Alimentary Pharmacology & Therapeutics, April 06, 2022
• Type 2 Diabetes-Prevention Diet and Mortality Is adherence to a type 2 diabetes-prevention diet an effective strategy for improving longevity?
  American Journal of Epidemiology, April 06, 2022
• Impact of Obesity in Kidney Transplantation In what ways might obesity impact kidney transplant outcomes?
  Nephrology Dialysis Transplantation, April 05, 2022
• Assessing Liver Steatosis in the Obese Before Bariatric Surgery Is the ultrasound-based controlled attenuation parameter accurate for grading liver steatosis among individuals with morbid obesity before and after bariatric surgery?
  Liver International, April 04, 2022
• Chronic Hepatitis D--What Is Changing? Several new approaches to hepatitis D virus therapy have been explored in recent years. Review these advances and novel therapeutic options for HDV in this paper.
  Journal of Viral Hepatitis, April 04, 2022
• Hepatitis D Hospitalizations in the U.S.: 2010-2018 A new study provides insight into the hospitalization rates of hepatitis D in the U.S. and the various characteristics of these patients.
  Journal of Viral Hepatitis, March 31, 2022
• Prognosis of Patients With MAFLD by Non-invasive Methods Can non-invasive methods accurately predict global and liver-related mortality and morbidity in patients with MAFLD?
  Alimentary Pharmacology & Therapeutics, March 29, 2022
• Glycosylated 4-methylumbelliferone as Targeted Therapy for HCC This study found that glycosylation of 4MUR can improve its selectivity to tumor cells and may potentially be an effective targeted therapy for hepatocellular carcinoma.
  Liver International, March 28, 2022
• Liver-related and Extrahepatic Events in Patients With NAFLD This study evaluated the probability of developing liver-related events and extrahepatic events, considered as competing risks, in patients with NAFLD, stratified by fibrosis stage.
  Alimentary Pharmacology & Therapeutics, March 24, 2022
• Artificial Intelligence in the Diagnosis of Esophageal Diseases This review summarizes and evaluates the latest evidence for the use of AI in the diagnosis of both malignant and benign esophageal diseases.
  Alimentary Pharmacology & Therapeutics, March 22, 2022
• Long-Term Prognosis in Alcohol-related Liver Disease or NAFLD Metabolic syndrome and alcohol use frequently co-exist. This study assessed survival in patients with NAFLD according to alcohol use and ALD according to the presence of metabolic syndrome.
  Liver International, March 21, 2022
• Serological Tests to Support the Diagnosis of Celiac Disease Might non-invasive serological tests accurately diagnose celiac disease in adults and children?
  Alimentary Pharmacology & Therapeutics, March 17, 2022